Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Authors › Posts by Matthew Perrone

Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

Business

FDA finds contamination issues at Ameridose

Matthew Perrone · November 12, 2012 11:52 pm
Business

Lawmakers issue subpoena for pharmacy director

Matthew Perrone · November 6, 2012 10:07 pm
Business

FDA: Pharmacy tied to outbreak knew of bacteria

Matthew Perrone · October 26, 2012 11:21 pm
Business

Lawmakers seek more regulation of compounded drugs

Matthew Perrone · October 10, 2012 1:11 am
Business

Defective generic pill revives quality concerns

Matthew Perrone · October 4, 2012 10:42 pm
Business

FDA says Teva antidepressant is ineffective

Matthew Perrone · October 3, 2012 8:58 pm
Business

Public Citizen: State drug fraud cases on the rise

Matthew Perrone · September 27, 2012 2:48 pm
Business

Saving money with smart open enrollment changes

Matthew Perrone · September 26, 2012 6:35 pm
Business

Pfizer pays $60 million to settle bribery charges

Matthew Perrone · August 7, 2012 5:19 pm
News

23andMe seeks FDA approval for personal DNA test

Matthew Perrone · July 30, 2012 4:25 pm
Business

23andMe seeks FDA approval for personal DNA test

Matthew Perrone · July 30, 2012 4:02 pm
News

Many drugs remain legal after “bath salts” ban

Matthew Perrone · July 25, 2012 2:39 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • ›Next page
Page 12 of 13
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement